177 related articles for article (PubMed ID: 21914223)
81. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
[TBL] [Abstract][Full Text] [Related]
82. Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells.
Sunada S; Cartwright IM; Hirakawa H; Fujimori A; Uesaka M; Kato TA
Oncol Lett; 2017 Jun; 13(6):4911-4916. PubMed ID: 28599495
[TBL] [Abstract][Full Text] [Related]
83. The relative biological effectiveness of densely ionizing heavy-ion radiation for inducing ocular cataracts in wild type versus mice heterozygous for the ATM gene.
Hall EJ; Worgul BV; Smilenov L; Elliston CD; Brenner DJ
Radiat Environ Biophys; 2006 Jul; 45(2):99-104. PubMed ID: 16799786
[TBL] [Abstract][Full Text] [Related]
84. RBE for carbon track-segment irradiation in cell lines of differing repair capacity.
Weyrather WK; Ritter S; Scholz M; Kraft G
Int J Radiat Biol; 1999 Nov; 75(11):1357-64. PubMed ID: 10597910
[TBL] [Abstract][Full Text] [Related]
85. Characteristic 8 keV X rays possess radiobiological properties of higher-LET radiation.
Shridhar R; Estabrook W; Yudelev M; Rakowski J; Burmeister J; Wilson GD; Joiner MC
Radiat Res; 2010 Mar; 173(3):290-7. PubMed ID: 20199214
[TBL] [Abstract][Full Text] [Related]
86. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
[TBL] [Abstract][Full Text] [Related]
87. Characterization of cancer stem-like cells in chordoma.
Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
[TBL] [Abstract][Full Text] [Related]
88. High-LET radiation induces apoptosis in lymphoblastoid cell lines derived from atazia-telangiectasia patients.
Meijer AE; Ekedahl J; Joseph B; Castro J; Harms-Ringdahl M; Zhivotovsky B; Lewensohn R
Int J Radiat Biol; 2001 Mar; 77(3):309-17. PubMed ID: 11258845
[TBL] [Abstract][Full Text] [Related]
89. Comparative analysis of G2 arrest after irradiation with 75 keV carbon-ion beams and 137Cs gamma-rays in a human lymphoblastoid cell line.
Matsumura S; Matsumura T; Ozeki S; Fukushima S; Yamazaki H; Inoue T; Inoue T; Furusawa Y; Eguchi-Kasai K
Cancer Detect Prev; 2003; 27(3):222-8. PubMed ID: 12787730
[TBL] [Abstract][Full Text] [Related]
90. U-CH17P, -M and -S, a new cell culture system for tumor diversity and progression in chordoma.
Jäger D; Lechel A; Tharehalli U; Seeling C; Möller P; Barth TFE; Mellert K
Int J Cancer; 2018 Apr; 142(7):1369-1378. PubMed ID: 29148152
[TBL] [Abstract][Full Text] [Related]
91. Resolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cells.
El-Heliebi A; Kroneis T; Wagner K; Meditz K; Kolb D; Feichtinger J; Thallinger GG; Quehenberger F; Liegl-Atzwanger B; Rinner B
PLoS One; 2014; 9(2):e87663. PubMed ID: 24503940
[TBL] [Abstract][Full Text] [Related]
92. Is there a role for immune checkpoint inhibitors in chordoma?
Assi T
Immunotherapy; 2021 Aug; 13(12):967-970. PubMed ID: 34078088
[No Abstract] [Full Text] [Related]
93. High-Throughput/High Content Imaging Screen Identifies Novel Small Molecule Inhibitors and Immunoproteasomes as Therapeutic Targets for Chordoma.
Ajay AK; Chu P; Patel P; Deban C; Roychowdhury C; Heda R; Halawi A; Saad A; Younis N; Zhang H; Jiang X; Nasr M; Hsiao LL; Lin G; Azzi JR
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111759
[TBL] [Abstract][Full Text] [Related]
94. A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma.
Zhao C; Tan T; Zhang E; Wang T; Gong H; Jia Q; Liu T; Yang X; Zhao J; Wu Z; Wei H; Xiao J; Yang C
Front Oncol; 2022; 12():1029670. PubMed ID: 36465398
[TBL] [Abstract][Full Text] [Related]
95. Genomic study and lipidomic bioassay of
Gattoni G; de la Haba RR; Martín J; Reyes F; Sánchez-Porro C; Feola A; Zuchegna C; Guerrero-Flores S; Varcamonti M; Ricca E; Selem-Mojica N; Ventosa A; Corral P
Front Microbiol; 2022; 13():1090197. PubMed ID: 36687661
[TBL] [Abstract][Full Text] [Related]
96. Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells.
Hoke ATK; Padget MR; Fabian KP; Nandal A; Gallia GL; Bilusic M; Soon-Shiong P; Hodge JW; London NR
Cancer Res Commun; 2021 Dec; 1(3):127-139. PubMed ID: 35765577
[TBL] [Abstract][Full Text] [Related]
97. Biological Effects of Monoenergetic Carbon Ions and Their Associated Secondary Particles.
Buglewicz DJ; Walsh KD; Hirakawa H; Kitamura H; Fujimori A; Kato TA
Front Oncol; 2022; 12():788293. PubMed ID: 35251969
[TBL] [Abstract][Full Text] [Related]
98. Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy.
Johnson AM; Bennett PV; Sanidad KZ; Hoang A; Jardine JH; Keszenman DJ; Wilson PF
Front Oncol; 2021; 11():735940. PubMed ID: 34513712
[TBL] [Abstract][Full Text] [Related]
99. Enhancement of Radio-Thermo-Sensitivity of 5-Iodo-2-Deoxyuridine-Loaded Polymeric-Coated Magnetic Nanoparticles Triggers Apoptosis in U87MG Human Glioblastoma Cancer Cell Line.
Khoei S; Hosseini V; Hosseini M; Khoee S; Shirvalilou S; Mahdavi SR; Pirayesh Islamian J
Cell Mol Bioeng; 2021 Aug; 14(4):365-377. PubMed ID: 34295445
[TBL] [Abstract][Full Text] [Related]
100. Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models.
Locquet MA; Dechaume AL; Berchard P; Abbes L; Pissaloux D; Tirode F; Ramos I; Bedoucha J; Valantin J; Karanian M; Perret R; Gille O; Blay JY; Dutour A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
